A comparison of Doppler flowmetry with conventional assessment of acute changes in hepatic blood flow

被引:7
作者
Gibson, PR
Gibson, RN
Donlan, JD
Jones, PA
Colman, JC
Dudley, FJ
机构
[1] UNIV MELBOURNE,ROYAL MELBOURNE HOSP,DEPT MED,PARKVILLE,VIC 3052,AUSTRALIA
[2] UNIV MELBOURNE,ROYAL MELBOURNE HOSP,DEPT RADIOL,PARKVILLE,VIC 3052,AUSTRALIA
[3] ALFRED HOSP,GASTROENTEROL UNIT,PRAHRAN,VIC 3181,AUSTRALIA
关键词
cirrhosis; Doppler; drug therapy; indocyanine green; portal hypertension; serotonin antagonist; ultrasound;
D O I
10.1111/j.1440-1746.1996.tb00004.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The validity and clinical relevance of Doppler flowmetry in measuring changes in regional blood flow are uncertain. In the present study we compared changes induced by ketanserin in regional splanchnic blood flow as measured by Doppler flowmetry with changes in conventionally measured systemic and in hepatic haemodynamic indices estimated pharmacokinetically using indocyanine green. Fourteen patients with alcoholic cirrhosis and portal hypertension were evaluated. On multivariate analyses, significant associations were noted for only three indices: changes in estimated hepatic blood flow were predicted jointly by changes in flow in the main and right portal veins and hepatic artery (R(2) = 0.80); changes in intrahepatic shunting (indocyanine green extraction) were predicted by changes in flow in the main and right portal veins (R(2) = 0.55); and changes in sinusoidal perfusion (indocyanine green clearance) were significantly predicted by changes in main portal vein flow alone (R(2) = 0.76). These data support the validity of Doppler flowmetry in quantifying change in regional blood flow, but highlight the limitations in its clinical application and interpretation. The association of changes in main portal vein flow with changes in sinusoidal perfusion has clinical potential but requires confirmation using other modulating drugs.
引用
收藏
页码:14 / 20
页数:7
相关论文
共 16 条
[1]   DOPPLER FLOWMETRY IN PORTAL-HYPERTENSION [J].
BOLONDI, L ;
BASSI, SL ;
GAIANI, S ;
BARBARA, L .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1990, 5 (04) :459-467
[2]   EFFECTS OF PROPRANOLOL ON AZYGOUS VENOUS-BLOOD FLOW AND HEPATIC AND SYSTEMIC HEMODYNAMICS IN CIRRHOSIS [J].
BOSCH, J ;
MASTI, R ;
KRAVETZ, D ;
BRUIX, J ;
GAYA, J ;
RIGAU, J ;
RODES, J .
HEPATOLOGY, 1984, 4 (06) :1200-1205
[3]   MEASUREMENT OF AZYGOUS VENOUS-BLOOD FLOW BY A CONTINUOUS THERMAL DILUTION TECHNIQUE - AN INDEX OF BLOOD-FLOW THROUGH GASTROESOPHAGEAL COLLATERALS IN CIRRHOSIS [J].
BOSCH, J ;
GROSZMANN, RJ .
HEPATOLOGY, 1984, 4 (03) :424-429
[4]   DOPPLER FLOWMETRY AND PORTAL-HYPERTENSION [J].
BURNS, P ;
TAYLOR, K ;
BLEI, AT .
GASTROENTEROLOGY, 1987, 92 (03) :824-826
[5]  
BURNS PN, 1985, RADIOL CLIN N AM, V23, P641
[6]  
CALES P, 1984, J HEPATOL, V1, P37
[7]  
COLMAN J, 1991, HEPATOLOGY, V4, pA237
[8]   EFFECT OF PROPRANOLOL ON PORTOSYSTEMIC COLLATERAL CIRCULATION IN PATIENTS WITH CIRRHOSIS [J].
GAIANI, S ;
BOLONDI, L ;
FENYVES, D ;
ZIRONI, G ;
RIGAMONTI, A ;
BARBARA, L .
HEPATOLOGY, 1991, 14 (05) :824-829
[9]   HEMODYNAMIC AND LIVER-FUNCTION PREDICTORS OF SERUM HYALURONAN IN ALCOHOLIC LIVER-DISEASE [J].
GIBSON, PR ;
FRASER, JRE ;
BROWN, TJ ;
FINCH, CF ;
JONES, PA ;
COLMAN, JC ;
DUDLEY, FJ .
HEPATOLOGY, 1992, 15 (06) :1054-1059
[10]   PATHO-PHYSIOLOGY OF PORTAL-HYPERTENSION AND IMPLICATIONS FOR ITS PHARMACOLOGICAL CONTROL [J].
GIBSON, PR ;
DUDLEY, FJ .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1989, 19 (02) :172-182